Cargando…
Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients
BACKGROUND: Gallbladder carcinoma is highly aggressive and resistant to chemotherapy, with no consistent strategy to guide first line chemotherapy. However, patient-derived xenograft (PDX) model has been increasingly used as an effective model for in preclinical study of chemosensitivity. METHODS: M...
Autores principales: | Zhan, Ming, Yang, Rui-meng, Wang, Hui, He, Min, Chen, Wei, Xu, Sun-wang, Yang, Lin-hua, Liu, Qiang, Long, Man-mei, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050666/ https://www.ncbi.nlm.nih.gov/pubmed/30016995 http://dx.doi.org/10.1186/s40880-018-0318-8 |
Ejemplares similares
-
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
por: Zhang, Feifei, et al.
Publicado: (2018) -
Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
por: Tan, Dengxu, et al.
Publicado: (2022) -
Impact of insurance status on the survival of gallbladder cancer patients
por: Chen, Zhiqiang, et al.
Publicado: (2017) -
Patient-Derived Xenograft Models for Intrahepatic Cholangiocarcinoma and Their Application in Guiding Personalized Medicine
por: Gao, Yang, et al.
Publicado: (2021) -
Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma
por: Bo, Xiaobo, et al.
Publicado: (2017)